FINAL REPORT
FLINDERS UNIVERSITY and SOUTHERN ADELAIDE LOCAL HEALTH NETWORK
For year ending 31 December 2015
[Pursuant to the Australian Code for the Care and Use of Animals for Scientific Purposes, 8th edition, 2013]
Instructions
Use this form for Discontinued or Completed projects
Please email the signed and completed report to animal.welfare@flinders.edu.au
PROJECT NUMBER
PROJECT TITLE
APPROVAL DATE
COMMENCEMENT DATE
ORIGINAL EXPIRY DATE
CURRENT EXPIRY DATE
MODIFICATIONS SINCE APPROVAL ( Including PENDING modifications) (Duplicate rows as required)
Modification
Approval Date
Type of Modification Approved
(a) Extension of time (b) Modified or additional experimental steps; additional / change to animals / species
(c) Change of personnel
NAME (Title, First Name, Family Name)
SCHOOL/DEPARTMENT/ORGANISATION
SUPERVISOR (If applicable)
DAY TIME PHONE NO.
EMAIL ADDRESS
FAX NO.
3.1 Status of Project: Is the project:
Not Commenced, terminated Commenced, but Abandoned Suspended permanently Completed
3.2 If not commenced or commenced, but abandoned, or suspended please state reason.
For projects Not Commenced and terminated, please go to Section 8, Certification and Signatures.

FINAL REPORT
NB: Please replicate the following table if more than one Category of Animal is used in this project and/or add additional rows to the Animal Type/s section, as necessary.
4.1 ANIMAL CATEGORY Refer to attached Animal Category/Type classification table Please tick ONE only
Aquatic
Bird
Domestic
Exotic Feral
Laboratory Mammals
Native Mammals
Primate
Reptile
Stock
Zoo
4.2 ANIMAL TYPE/S
Please select from type listed for the category you have specified above: see attached Animal
Category/Type classification table
GM
Yes or
No
ANIMAL IMPACT /
PROCEDURE TYPE
Please select from attached table; if more than one procedure, record only the most invasive
TOTAL
NUMBER
APPROVED
(incl. modifications)
TOTAL
NUMBER
ACTUALLY
USED
TO DATE
TOTAL
NUMBER
USED
BETWEEN
1/1/2015 &
31/12/2015
5.1 For completed projects, please briefly outline progress to date, or summary of results. (Final reports to funding bodies may be attached.)
5.2 Were there any problems that interfered with the progress of the project?
Yes No
Briefly explain the problems:
5.3 Did any unexpected adverse events OR animal welfare issues arise that were inconsistent with those anticipated in the original proposal or an approved modification?
Yes No
If yes, please briefly explain:
5.4 How many Unexpected Adverse Event Reports have been submitted?
5.4.1 Number of reports submitted between 01/01/2015 & 31/12/2015:
5.4.2 Number of reports submitted since Approval:
5.4.3 Total mortality rate experienced since Approval:

FINAL REPORT
5.5 Were there any modifications to the project that have not been referred to the AWC for approval?
Yes No
If yes, please briefly explain:
5.6 Did the project meet the aims stated in the original proposal?
Yes No
If no, please outline why.
6.1 What did you do to reduce any impact on animal welfare, or what plans do you have to facilitate this in
future projects?
7.1 Publications resulting from the project. List full citation detail – please use style appropriate to your discipline
7.2 Conference presentations. Detail conference title, date, title of presentation, presenter
7.3 Research Higher Degree completions: Student name/s, type of degree, date of thesis submission/award of degree
7.4 Award of patent/s? If so, please provide dates of application and award
7.5 Has this study generated data for new funding submission/s? if so, please indicate: a. Name of granting body b. Title of funding application c. Chief Investigator d. Institution if other than Flinders/SAHS e. Date of application f. Outcome – Funded / not funded / pending
(circle as appropriate)

FINAL REPORT
7.6 Have there been any other noteworthy outcomes from this project? If so, please provide details
I, the Chief Investigator for this project, certify that, except where indicated above, this research project has been conducted in accordance with the approved protocol.
Name: Signature:
Date:

FINAL REPORT
Attachment: Classifications of Animal Type by Category and Definitions of Animal Impact / Procedure
Please delete this page from completed report form before submitting.
Higher category Lower category
Amphibians Amphibians
Aquatic Animals Cephalopods, Crustaceans, Fish, other aquatic animals
Birds
Domestic
Mammals
Exotic Feral
Mammals
Exotic Captive, Exotic Wild, Native Captive, Native Wild, Poultry, other birds
Cats, Dogs, Cattle, Deer, Goats, Horses, Pigs, Sheep, other domestic mammals
Camels, Cats, Cattle, Goats, Hares, Horses, Mice, Pigs, Rabbits, Rats,
Wild Dogs and Foxes, other exotic feral mammals
Laboratory
Mammals
Ferrets, Guinea Pigs, Hamsters, Mice, Rabbits, Rats, other laboratory mammals
Native Mammals
Dasyurids, Koalas, Macropods, Native Rats and Mice, Possums and
Gliders, Wombats, Monotremes, Seals, Whales and Dolphins, other native mammals
Primates Baboons, Macaques, Marmosets, other primates
Reptiles
Exotic Zoo
Animals
Lizards, Snakes, Turtles and Tortoises, other reptiles
Exotic Zoo Animals
Only one type of procedure per entry should be recorded. The basis for the decision should be based on the following National Health and Medical Research Council (NHMRC) criteria:
Observation with Minor Interference – Breeding, Reproductive, Genetic or
Behavioural Study; Feeding trial
Animal Unconscious No Recovery – Animals killed painlessly for biochemical analysis, in vitro cell tissue or organ studies; Animal are fully anaesthetised for duration and killed in conclusion without recovery from anaesthesia
Minor Conscious Procedure – Injections, blood sampling, minor dietary or environmental manipulation
Minor Operative Procedure with Recovery – Biopsies, cannulations
Surgery with Recovery – Orthopaedic, abdominal or thoracic
Minor Physiological Challenge – Minor infections, minor or moderate genetic modification, early oncogenesis; Arthritis studies with pain alleviation, controlled metabolic disease; Residue testing; polyclonal antibody production
Physiological Challenge – Major infection, major genetic modification, oncogenesis without pain relief; Arthritis studies with no pain alleviation, uncontrolled metabolic disease; Isolation or environmental deprivation for extended periods; Monoclonal antibody raising in mice.
Death as an Endpoint, Lethality testing, Vaccination trials.